Paper · 41694374
CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2-CCL2, CCR5-CCL5, CCR4-CCL17/22, CCR6-CCL20, CCR7-CCL19/21.
Bahng I. Front Immunol, 2026. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2-CCL2, CCR5-CCL5, CCR4-CCL17/22, CCR6-CCL20, CCR7-CCL19/21. Papers, record 41694374. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41694374
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2-CCL2, CCR5-CCL5, CCR4-CCL17/22, CCR6-CCL20, CCR7-CCL19/21.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Pancreatic Ductal | Major topic |
| Pancreatic Neoplasms | Major topic |
| Receptors, CCR | Major topic |
| Humans | |
| Animals | |
| Signal Transduction | |
| Tumor Microenvironment |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References224
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36,256,464 | Targeting TNF-α-producing macrophages activates antitumor immunity in pancreatic cancer via IL-33 signaling. | JCI Insight | 2022 | https://conductscience.org/library/papers/36256464 | PubMed |
| 2 | 27,271,610 | Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27271610 | PubMed |
| 3 | 20,053,993 | c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20053993 | PubMed |
| 4 | 23,547,054 | GSK-3α promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-κB. | Cancer Discov | 2013 | https://conductscience.org/library/papers/23547054 | PubMed |
| 5 | 21,671,175 | Role of RANTES and its receptor in gastric cancer metastasis. | J Huazhong Univ Sci Technolog Med Sci | 2011 | https://conductscience.org/library/papers/21671175 | PubMed |
| 6 | 27,429,508 | Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma. | Dis Markers | 2016 | https://conductscience.org/library/papers/27429508 | PubMed |
| 7 | 35,358,941 | CCR4+ monocytic myeloid-derived suppressor cells are associated with the increased epithelial-mesenchymal transition in pancreatic adenocarcinoma patients. | Immunobiology | 2022 | https://conductscience.org/library/papers/35358941 | PubMed |
| 8 | 10,648,464 | Differential expression of chemokines in normal pancreas and in chronic pancreatitis. | Gastroenterology | 2000 | https://conductscience.org/library/papers/10648464 | PubMed |
| 9 | 26,191,284 | Changes of Th17/Treg cell and related cytokines in pancreatic cancer patients. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/26191284 | PubMed |
| 10 | 11,072,146 | Pancreatic tumors show high levels of hypoxia. | Int J Radiat Oncol Biol Phys | 2000 | https://conductscience.org/library/papers/11072146 | PubMed |
1 to 10 of 224
See all 224 referencesCited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,921,511 | Chemokine-receptor axes in immune-tumor cell communication: spatial niches, immune exclusion, and therapy resistance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42921511 | PubMed |
| 42,903,166 | TREM2+ macrophages mediate anticancer therapy-induced immune evasion in lung adenocarcinoma via the CCL5/CCL22-Treg axis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42903166 | PubMed |
| 42,877,588 | Innate immunity-stroma crosstalk in pancreatic cancer: overcoming spatial and metabolic barriers to immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42877588 | PubMed |
| 41,694,374 | CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2-CCL2, CCR5-CCL5, CCR4-CCL17/22, CCR6-CCL20, CCR7-CCL19/21. | Front Immunol | 2026 | https://conductscience.org/library/papers/41694374 | PubMed |
Genes73
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| BRD4 | 23,476 | PubTator's text mining | https://conductscience.org/library/genes/23476 | NCBI Gene |
| CCL1 | 6,346 | PubTator's text mining | https://conductscience.org/library/genes/6346 | NCBI Gene |
| CCL16 | 6,360 | PubTator's text mining | https://conductscience.org/library/genes/6360 | NCBI Gene |
| CCL17 | 6,361 | PubTator's text mining | https://conductscience.org/library/genes/6361 | NCBI Gene |
| CCL19 | 6,363 | PubTator's text mining | https://conductscience.org/library/genes/6363 | NCBI Gene |
| CCL2 | 6,347 | PubTator's text mining | https://conductscience.org/library/genes/6347 | NCBI Gene |
| CCL20 | 6,364 | PubTator's text mining | https://conductscience.org/library/genes/6364 | NCBI Gene |
| CCL21 | 6,366 | PubTator's text mining | https://conductscience.org/library/genes/6366 | NCBI Gene |
| CCL22 | 6,367 | PubTator's text mining | https://conductscience.org/library/genes/6367 | NCBI Gene |
1 to 10 of 73
See all 73 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41694374
GET https://conductscience.org/api/papers/v1/41694374/references?page=2